Bakker AB - Search Results

1

Identification of a novel peptide derived from the melanocyte-specific gp100 antigen as the dominant epitope recognized by an HLA-A2.1-restricted anti-melanoma CTL line.

Bakker AB, Schreurs MW, Tafazzul G, de Boer AJ, Kawakami Y, Adema GJ, Figdor CG. Bakker AB, et al. Int J Cancer. 1995 Jul 4;62(1):97-102. doi: 10.1002/ijc.2910620118. Int J Cancer. 1995. PMID: 7541395 Free article.

2

Generation of antimelanoma cytotoxic T lymphocytes from healthy donors after presentation of melanoma-associated antigen-derived epitopes by dendritic cells in vitro.

Bakker AB, Marland G, de Boer AJ, Huijbens RJ, Danen EH, Adema GJ, Figdor CG. Bakker AB, et al. Cancer Res. 1995 Nov 15;55(22):5330-4. Cancer Res. 1995. PMID: 7585596

3

Melanocyte lineage-specific antigen gp100 is recognized by melanoma-derived tumor-infiltrating lymphocytes.

Bakker AB, Schreurs MW, de Boer AJ, Kawakami Y, Rosenberg SA, Adema GJ, Figdor CG. Bakker AB, et al. J Exp Med. 1994 Mar 1;179(3):1005-9. doi: 10.1084/jem.179.3.1005. J Exp Med. 1994. PMID: 8113668 Free PMC article.

4

pMel17 is recognised by monoclonal antibodies NKI-beteb, HMB-45 and HMB-50 and by anti-melanoma CTL.

Adema GJ, Bakker AB, de Boer AJ, Hohenstein P, Figdor CG. Adema GJ, et al. Among authors: bakker ab. Br J Cancer. 1996 May;73(9):1044-8. doi: 10.1038/bjc.1996.202. Br J Cancer. 1996. PMID: 8624261 Free PMC article.

5

Analogues of CTL epitopes with improved MHC class-I binding capacity elicit anti-melanoma CTL recognizing the wild-type epitope.

Bakker AB, van der Burg SH, Huijbens RJ, Drijfhout JW, Melief CJ, Adema GJ, Figdor CG. Bakker AB, et al. Int J Cancer. 1997 Jan 27;70(3):302-9. doi: 10.1002/(sici)1097-0215(19970127)70:3<302::aid-ijc10>3.0.co;2-h. Int J Cancer. 1997. PMID: 9033632 Free article.

6

Transcription of the gene encoding melanoma-associated antigen gp100 in tissues and cell lines other than those of the melanocytic lineage.

Brouwenstijn N, Slager EH, Bakker AB, Schreurs MW, Van der Spek CW, Adema GJ, Schrier PI, Figdor CG. Brouwenstijn N, et al. Among authors: bakker ab. Br J Cancer. 1997;76(12):1562-6. doi: 10.1038/bjc.1997.597. Br J Cancer. 1997. PMID: 9413942 Free PMC article.

7

Dendritic cells in immune response induction.

Marland G, Bakker AB, Adema GJ, Figdor CG. Marland G, et al. Among authors: bakker ab. Stem Cells. 1996 Sep;14(5):501-7. doi: 10.1002/stem.140501. Stem Cells. 1996. PMID: 8888491 Review.

8

Killer cell inhibitory receptors for MHC class I molecules regulate lysis of melanoma cells mediated by NK cells, gamma delta T cells, and antigen-specific CTL.

Bakker AB, Phillips JH, Figdor CG, Lanier LL. Bakker AB, et al. J Immunol. 1998 Jun 1;160(11):5239-45. J Immunol. 1998. PMID: 9605119

9

Mac-1 (CD11b/CD18) is crucial for effective Fc receptor-mediated immunity to melanoma.

van Spriel AB, van Ojik HH, Bakker A, Jansen MJ, van de Winkel JG. van Spriel AB, et al. Among authors: bakker a. Blood. 2003 Jan 1;101(1):253-8. doi: 10.1182/blood.V101.1.253. Blood. 2003. PMID: 12485936 Free article.

10

Inside-out regulation of Fc alpha RI (CD89) depends on PP2A.

Bakema JE, Bakker A, de Haij S, Honing H, Bracke M, Koenderman L, Vidarsson G, van de Winkel JG, Leusen JH. Bakema JE, et al. J Immunol. 2008 Sep 15;181(6):4080-8. doi: 10.4049/jimmunol.181.6.4080. J Immunol. 2008. PMID: 18768864

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

163 results

Search Page

Filters